{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:19:51Z","timestamp":1787167191264,"version":"build-2736575974"},"reference-count":175,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:00:00Z","timestamp":1599350400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["290836"],"award-info":[{"award-number":["290836"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1194\/jlr.r086629","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T04:48:32Z","timestamp":1538628512000},"page":"2262-2276","update-policy":"https:\/\/doi.org\/10.1194\/jlr.f110.005975","source":"Crossref","is-referenced-by-count":15,"title":["Distinguishing the differences in \u03b2-glycosylceramidase folds, dynamics, and actions informs therapeutic uses"],"prefix":"10.1016","volume":"59","author":[{"given":"Fredj","family":"Ben Bdira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Artola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman S.","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellus","family":"Ubbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R086629_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/glycob\/4.6.759","article-title":"A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05x10(12) structures for a reducing hexasaccharide\u2013the isomer-barrier to development of single-method saccharide sequencing or synthesis systems","volume":"4","author":"Laine","year":"1994","journal-title":"Glycobiology."},{"key":"10.1194\/jlr.R086629_bib2","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1021\/ja9813055","article-title":"Spontaneous hydrolysis of glycosides","volume":"120","author":"Wolfenden","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.R086629_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.sbi.2005.10.008","article-title":"Recent structural insights into the expanding world of carbohydrate-active enzymes","volume":"15","author":"Davies","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1194\/jlr.R086629_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/2213235X03666150915211224","article-title":"Xylanase: applications in biofuel production","volume":"4","author":"Garg","year":"2016","journal-title":"Curr. Metabolomics."},{"key":"10.1194\/jlr.R086629_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcs.2005.08.002","article-title":"Use of glycoside hydrolase family 8 xylanases in baking","volume":"43","author":"Collins","year":"2006","journal-title":"J. Cereal Sci."},{"key":"10.1194\/jlr.R086629_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0957-4166(00)00113-0","article-title":"Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application","volume":"11","author":"Asano","year":"2000","journal-title":"Tetrahedron Asymmetry."},{"key":"10.1194\/jlr.R086629_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0959-440X(96)80038-8","article-title":"Design and synthesis of carbohydrate-based inhibitors of protein-carbohydrate interactions","volume":"6","author":"von Itzstein","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1194\/jlr.R086629_bib8","doi-asserted-by":"crossref","first-page":"93R","DOI":"10.1093\/glycob\/cwg090","article-title":"Glycosidase inhibitors: update and perspectives on practical use","volume":"13","author":"Asano","year":"2003","journal-title":"Glycobiology."},{"key":"10.1194\/jlr.R086629_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1194\/jlr.R086629_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00001574-200403000-00019","article-title":"Carbohydrate intolerance","volume":"20","author":"Sibley","year":"2004","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1194\/jlr.R086629_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BST20150186","article-title":"Carbohydrate-active enzymes: sequences, shapes, contortions and cells","volume":"44","author":"Davies","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1194\/jlr.R086629_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj2800309","article-title":"A classification of glycosyl hydrolases based on amino-acid-sequence similarities","volume":"280","author":"Henrissat","year":"1991","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.R086629_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0959-440X(97)80072-3","article-title":"Structural and sequence-based classification of glycoside hydrolases","volume":"7","author":"Henrissat","year":"1997","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1194\/jlr.R086629_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1098\/rstb.2003.1273","article-title":"Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention","volume":"358","author":"Aerts","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1194\/jlr.R086629_bib15","article-title":"De l'\u00e9pith\u00e9lioma primitif de la rate. Hyper\u00adtrophie idiopathique de la rate sans leuc\u00e9mie","author":"Gaucher","year":"1882","journal-title":"PhD Dissertation. University of Paris, Paris, France. French"},{"key":"10.1194\/jlr.R086629_bib16","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demon\u00adstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R086629_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid \u03b2-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J. Pathol."},{"key":"10.1194\/jlr.R086629_bib18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R086629_bib19","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocere\u00adbrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain."},{"key":"10.1194\/jlr.R086629_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0925-4439(93)90090-N","article-title":"Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease","volume":"1181","author":"van Weely","year":"1993","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R086629_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","article-title":"Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity","volume":"92","author":"Hammer","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.R086629_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"Martin","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.R086629_bib23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/gim.2015.139","article-title":"Novel mutations in genes causing hereditary spastic paraplegia and Charcot-Marie-Tooth neuropathy identified by an optimized protocol for homozygosity mapping based on whole-exome sequencing","volume":"18","author":"Kancheva","year":"2016","journal-title":"Genet. Med."},{"key":"10.1194\/jlr.R086629_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2015.07.112","article-title":"Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia\/cerebellar ataxia (SPG46)","volume":"465","author":"Sultana","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R086629_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1367-5931(00)00135-6","article-title":"Glycosidase mechanisms","volume":"4","author":"Rye","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2014.06.003","article-title":"Dissecting conformational contributions to glycosidase catalysis and inhibition","volume":"28","author":"Speciale","year":"2014","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1194\/jlr.R086629_bib27","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1021\/jacs.5b01156","article-title":"Reaction mechanisms in carbohydrate-active enzymes: glycoside hydrolases and glycosyltransferases. Insights from ab initio quantum mechanics\/molecular mechanics dynamic simulations","volume":"137","author":"Ard\u00e8vol","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.R086629_bib28","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1021\/acschembio.6b00340","article-title":"Advances in enzymatic glycoside synthesis","volume":"11","author":"Danby","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/glycob\/7.8.1237","article-title":"Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase","volume":"7","author":"Ribeir\u00e3o","year":"1997","journal-title":"Glycobiology."},{"key":"10.1194\/jlr.R086629_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0008-6215(02)00467-6","article-title":"Enzymatic synthesis of \u03b2-xylanase substrates: transglycosylation reactions of the \u03b2-xylosidase from Aspergillus sp","volume":"338","author":"Eneyskaya","year":"2003","journal-title":"Carbohydr. Res."},{"key":"10.1194\/jlr.R086629_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.carres.2003.12.007","article-title":"High efficiency of transferring a native sugar chain from a glycopeptide by a microbial endoglycosidase in organic solvents","volume":"339","author":"Akaike","year":"2004","journal-title":"Carbohydr. Res."},{"key":"10.1194\/jlr.R086629_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0969-2126(01)00220-9","article-title":"Structures and mechanisms of glycosyl hydrolases","volume":"3","author":"Davies","year":"1995","journal-title":"Structure."},{"key":"10.1194\/jlr.R086629_bib33","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.febslet.2010.09.051","article-title":"Consolidation of glycosyl hydrolase family 30: a dual domain 4\/7 hydrolase family consisting of two structurally distinct groups","volume":"584","author":"St John","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.R086629_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2148-12-186","article-title":"Evolution, substrate specificity and subfamily classification of glycoside hydrolase family 5 (GH5)","volume":"12","author":"Aspeborg","year":"2012","journal-title":"BMC Evol. Biol."},{"key":"10.1194\/jlr.R086629_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/glycob\/7.2.277","article-title":"Active-site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis","volume":"7","author":"Durand","year":"1997","journal-title":"Glycobiology."},{"key":"10.1194\/jlr.R086629_bib36","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1016\/S0021-9258(18)67015-2","article-title":"A novel glycosphingolipid-degrading enzyme cleaves the linkage between the oligosaccharide and ceramide of neutral and acidic glycosphingolipids","volume":"261","author":"Ito","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib37","doi-asserted-by":"crossref","first-page":"14300","DOI":"10.1074\/jbc.M611455200","article-title":"Structural and mechanistic analyses of endo-glycoceramidase II, a membrane-associated family 5 glycosidase in the Apo and GM3 ganglioside-bound forms","volume":"282","author":"Caines","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib38","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1074\/jbc.M116.763821","article-title":"Structural insights into the broad substrate specificity of a novel endoglycoceramidase I belonging to a new subfamily of GH5 glycosidases","volume":"292","author":"Han","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0006-291X(86)80375-8","article-title":"A unique glycosphingolipid-splitting enzyme (ceramide-glycanase from leech) cleaves the linkage between the oligosaccharide and the ceramide","volume":"141","author":"Li","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R086629_bib40","doi-asserted-by":"crossref","first-page":"12272","DOI":"10.1016\/S0021-9258(18)63853-0","article-title":"Isolation and characterization of ceramide glycanase from the leech, Macrobdella decora","volume":"264","author":"Zhou","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/bj2850619","article-title":"Ceramide glycanase from the earthworm, Lumbricus terrestris","volume":"285","author":"Carter","year":"1992","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.R086629_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/abio.1994.1484","article-title":"Analysis of glycosphingolipids by fluorophore-assisted carbohydrate electrophoresis using ceramide glycanase from Mercenaria mercenaria","volume":"222","author":"Basu","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1194\/jlr.R086629_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10719-017-9802-7","article-title":"Degradation of glycosphingolipids in oyster: ceramide glycanase and ceramidase in the hepatopancreas of oyster, Crassostrea virginica","volume":"35","author":"Pavlova","year":"2018","journal-title":"Glycoconj. J."},{"key":"10.1194\/jlr.R086629_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/A:1020220524180","article-title":"Ceramide glycanase activities in human cancer cells","volume":"19","author":"Basu","year":"1999","journal-title":"Biosci. Rep."},{"key":"10.1194\/jlr.R086629_bib45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0076-6879(00)11090-0","article-title":"Properties of animal ceramide glycanases","volume":"311","author":"Basu","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1194\/jlr.R086629_bib46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbrc.2013.10.145","article-title":"Cholesterol glucosylation is catalyzed by transglucosylation reaction of \u03b2-glucosidase 1","volume":"441","author":"Akiyama","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R086629_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1194\/jlr.M064923","article-title":"Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular \u03b2-glucosidases","volume":"57","author":"Marques","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R086629_bib48","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1021\/ja058469n","article-title":"Glycosynthase-mediated synthesis of glycosphingolipids","volume":"128","author":"Vaughan","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.R086629_bib49","doi-asserted-by":"crossref","first-page":"10806","DOI":"10.1039\/c1cc13885e","article-title":"Glycosphingolipid synthesis employing a combination of recombinant glycosyltransferases and an endoglycoceramidase glycosynthase","volume":"47","author":"Rich","year":"2011","journal-title":"Chem. Commun. (Camb.)."},{"key":"10.1194\/jlr.R086629_bib50","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1016\/S0021-9258(18)60561-7","article-title":"Purification and characterization of glycosphingolipid-specific endoglycosidases (endoglycoceramidases) from a mutant strain of Rhodococcus sp. Evidence for three molecular species of endoglycoceramidase with different specificities","volume":"264","author":"Ito","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib51","doi-asserted-by":"crossref","first-page":"11386","DOI":"10.1074\/jbc.M608445200","article-title":"A novel endoglycoceramidase hydrolyzes oligogalactosylceramides to produce galactooligosaccharides and ceramides","volume":"282","author":"Ishibashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1074\/jbc.M111.311340","article-title":"Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1)","volume":"287","author":"Ishibashi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib53","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.M114.616300","article-title":"Sterylglucoside catabolism in Cryptococcus neoformans with endoglycoceramidase-related protein 2 (EGCrP2), the first steryl-\u03b2-glucosidase identified in fungi","volume":"290","author":"Watanabe","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib54","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/glycob\/cwv045","article-title":"Ergosteryl-\u03b2-glucosidase (Egh1) involved in sterylglucoside catabolism and vacuole formation in Saccharomyces cerevisiae","volume":"25","author":"Watanabe","year":"2015","journal-title":"Glycobiology."},{"key":"10.1194\/jlr.R086629_bib55","doi-asserted-by":"crossref","first-page":"20691","DOI":"10.1074\/jbc.M109.086470","article-title":"A new archaeal \u03b2-glycosidase from sulfolobus solfataricus seeding a novel retaining \u03b2-glycan-specific glycoside hydrolase family along with the human non-lysosomal glucosylceramidase GBA2","volume":"285","author":"Cobucci-Ponzano","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib56","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1074\/jbc.M114.593376","article-title":"A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid\/base residues in human retaining \u03b2-glucosidases","volume":"289","author":"Kallemeijn","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib57","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/acschembio.6b00192","article-title":"Bacterial \u03b2-glucosidase reveals the structural and functional basis of genetic defects in human glucocerebrosidase 2 (GBA2)","volume":"11","author":"Charoenwattanasatien","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib58","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of \u03b2-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R086629_bib59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as \u03b2-glucosidase 2","volume":"282","author":"Boot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib60","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1074\/jbc.M112.414714","article-title":"The non-lysosomal \u03b2-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi","volume":"288","author":"K\u00f6rschen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib61","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.1074\/jbc.M702387200","article-title":"Accumulation of glucosylceramide in murine testis, caused by inhibition of \u03b2-glucosidase 2: implications for spermatogenesis","volume":"282","author":"Walden","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib62","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.pgen.1005063","article-title":"Accumulation of glucosylceramide in the absence of the beta-glucosidase GBA2 alters cytoskeletal dynamics","volume":"11","author":"Raju","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1194\/jlr.R086629_bib63","doi-asserted-by":"crossref","first-page":"18744","DOI":"10.1016\/S0021-9258(19)37024-3","article-title":"Location of the two catalytic sites in intestinal lactase-phlorizin hydrolase. Comparison with sucrase-isomaltase and with other glycosidases, the membrane anchor of lactase-phlorizin hydrolase","volume":"267","author":"Wacker","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/adc.45.240.173","article-title":"Congenital lactose malabsorption","volume":"45","author":"Levin","year":"1970","journal-title":"Arch. Dis. Child."},{"key":"10.1194\/jlr.R086629_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcmd.2010.07.009","article-title":"The cytosolic \u03b2-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation","volume":"46","author":"Dekker","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1194\/jlr.R086629_bib66","doi-asserted-by":"crossref","first-page":"30889","DOI":"10.1074\/jbc.M700832200","article-title":"Klotho-related protein is a novel cytosolic neutral \u03b2-glycosylceramidase","volume":"282","author":"Hayashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbrc.2008.07.089","article-title":"Crystal structure of the covalent intermediate of human cytosolic \u03b2-glucosidase","volume":"374","author":"Noguchi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R086629_bib68","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jmb.2007.05.034","article-title":"The crystal structure of human cytosolic \u03b2-glucosidase unravels the substrate aglycone specificity of a family 1 glycoside hydrolase","volume":"370","author":"Tribolo","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1194\/jlr.R086629_bib69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000133703","article-title":"Regional mapping of the human galactocerebrosidase gene (GALC) to 14q31 by in situ hybridization","volume":"66","author":"Cannizzaro","year":"1994","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1194\/jlr.R086629_bib70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.jbchem.a124569","article-title":"Purification and characterization of galactocerebrosidase from human lymphocytes","volume":"116","author":"Sakai","year":"1994","journal-title":"J. Biochem."},{"key":"10.1194\/jlr.R086629_bib71","doi-asserted-by":"crossref","first-page":"15169","DOI":"10.1073\/pnas.1105639108","article-title":"Insights into Krabbe disease from structures of galactocerebrosidase","volume":"108","author":"Deane","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R086629_bib72","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0014-5793(97)01302-1","article-title":"Saposins (sap) A and C activate the degradation of galactosylceramide in living cells","volume":"417","author":"Harzer","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.R086629_bib73","doi-asserted-by":"crossref","first-page":"20479","DOI":"10.1073\/pnas.1311990110","article-title":"Structural snapshots illustrate the catalytic cycle of \u03b2-galactocerebrosidase, the defective enzyme in Krabbe disease","volume":"110","author":"Hill","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R086629_bib74","doi-asserted-by":"crossref","first-page":"E1894","DOI":"10.1002\/humu.21367","article-title":"Identificationand characterization of 15 novel GALC gene mutations causing Krabbe disease","volume":"31","author":"Tappino","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1194\/jlr.R086629_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1022436928925","article-title":"Twenty five years of the \u201cpsychosine hypothesis\u201d: a personal perspective of its history and present status","volume":"23","author":"Suzuki","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1194\/jlr.R086629_bib76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00005072-199407000-00006","article-title":"A genetic demyelinating disease globoid cell leukodystrophy: studies with animal models","volume":"53","author":"Suzuki","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1194\/jlr.R086629_bib77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2015.12.006","article-title":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","volume":"117","author":"Ferraz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1194\/jlr.R086629_bib78","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R086629_bib79","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.R086629_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-152826-3.50010-3","article-title":"Receptor-mediated transport of acid hydrolases to lysosomes","volume":"26","author":"Sly","year":"1985","journal-title":"Curr. Top. Cell. Regul."},{"key":"10.1194\/jlr.R086629_bib81","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-4165(88)90030-X","article-title":"Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation","volume":"964","author":"Aerts","year":"1988","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R086629_bib82","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of \u03b2-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell."},{"key":"10.1194\/jlr.R086629_bib83","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1074\/jbc.M705005200","article-title":"Crystal structures of complexes of N-butyl-and N-nonyl-deoxynojirimycin bound to acid \u03b2-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease","volume":"282","author":"Brumshtein","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib84","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nature06522","article-title":"Dynamic personalities of proteins","volume":"450","author":"Henzler-Wildman","year":"2007","journal-title":"Nature."},{"key":"10.1194\/jlr.R086629_bib85","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/bi061694c","article-title":"NMR spectroscopic characterization of a beta-(1,4)-glycosidase along its reaction pathway: stabilization upon formation of the glycosyl-enzyme intermediate","volume":"46","author":"Poon","year":"2007","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R086629_bib86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1097-0134(19990501)35:2<163::AID-PROT3>3.0.CO;2-8","article-title":"Structural and dynamic aspects of beta-glycosidase from mesophilic and thermophilic bacteria by multitryptophanyl emission decay studies","volume":"35","author":"Bismuto","year":"1999","journal-title":"Proteins."},{"key":"10.1194\/jlr.R086629_bib87","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/cbic.201200302","article-title":"Characterization of the N370S mutant of glucocerebrosidase by hydrogen\/deuterium exchange mass spectrometry","volume":"13","author":"Tang","year":"2012","journal-title":"ChemBioChem."},{"key":"10.1194\/jlr.R086629_bib88","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/acschembio.7b00276","article-title":"Stabilization of glucocerebrosidase by active site occupancy","volume":"12","author":"Ben Bdira","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib89","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid \u03b2-glucosidases effects of Gaucher disease mutations","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib90","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","article-title":"Characterization of human glucocerebrosidase from different mutant alleles","volume":"266","author":"Ohashi","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1432-1033.1987.tb11008.x","article-title":"Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts","volume":"164","author":"Jonsson","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.R086629_bib92","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI116276","article-title":"Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease","volume":"91","author":"van Weely","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R086629_bib93","doi-asserted-by":"crossref","first-page":"42105","DOI":"10.1074\/jbc.M110.172098","article-title":"Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S","volume":"285","author":"Offman","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib94","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M110.150433","article-title":"X-ray and biochemical analysis of N370S mutant human acid \u03b2-glucosidase","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib95","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.clinbiochem.2015.06.004","article-title":"The effects of chemically synthesized saposin C on glucosylceramide-\u03b2-glucosidase","volume":"48","author":"Yoneshige","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1194\/jlr.R086629_bib96","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2015.01.024","article-title":"Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C","volume":"457","author":"Gruschus","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R086629_bib97","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1098\/rstb.2003.1269","article-title":"Enzyme replacement therapy: conception, chaos and culmination","volume":"358","author":"Brady","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1194\/jlr.R086629_bib98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2016.10.030","article-title":"Roscoe O. Brady: physician whose pioneering discoveries in lipid biochemistry revolutionized treatment and understanding of lysosomal diseases","volume":"68","author":"Aerts","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1194\/jlr.R086629_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1194\/jlr.R086629_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","article-title":"Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges","volume":"13","author":"Desnick","year":"2012","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1194\/jlr.R086629_bib101","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","article-title":"Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood."},{"key":"10.1194\/jlr.R086629_bib102","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ejcn.1602098","article-title":"Effect of exogenous beta-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study","volume":"59","author":"Montalto","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1194\/jlr.R086629_bib103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10620-006-9296-9","article-title":"The effect of oral \u03b1-galactosidase on intestinal gas production and gas-related symptoms","volume":"52","author":"Di Stefano","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1194\/jlr.R086629_bib104","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1016\/j.tet.2006.08.055","article-title":"\u03b1-and \u03b2-glucosidase inhibitors: chemical structure and biological activity","volume":"62","author":"de Melo","year":"2006","journal-title":"Tetrahedron."},{"key":"10.1194\/jlr.R086629_bib105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/clpt.1987.177","article-title":"A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus","volume":"42","author":"Kennedy","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1194\/jlr.R086629_bib106","first-page":"CD005061","article-title":"Alpha-glucosidase inhibitors for type 2 diabetes mellitus","volume":"18","author":"Van de Laar","year":"2006","journal-title":"Cochrane Libr."},{"key":"10.1194\/jlr.R086629_bib107","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.R086629_bib108","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1194\/jlr.R086629_bib109","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2011.569162","article-title":"Pharmacological chaperone therapy for Gaucher disease: a patent review","volume":"21","author":"Benito","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1194\/jlr.R086629_bib110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-9422(00)00451-9","article-title":"Polyhydroxylated alkaloids\u2013natural occurrence and therapeutic applications","volume":"56","author":"Watson","year":"2001","journal-title":"Phytochemistry."},{"key":"10.1194\/jlr.R086629_bib111","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/cr00105a006","article-title":"Catalytic mechanism of enzymic glycosyl transfer","volume":"90","author":"Sinnott","year":"1990","journal-title":"Chem. Rev."},{"key":"10.1194\/jlr.R086629_bib112","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1039\/b307455b","article-title":"A new access to polyhydroxy piperidines of the azasugar class: synthesis and glycosidase inhibition studies","volume":"1","author":"Pandey","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1194\/jlr.R086629_bib113","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1021\/ja010240u","article-title":"Noeuromycin, a glycosyl cation mimic that strongly inhibits glycosidases","volume":"123","author":"Liu","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.R086629_bib114","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of \u03b2-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"FEBS J."},{"key":"10.1194\/jlr.R086629_bib115","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib116","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.carres.2016.03.007","article-title":"Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease","volume":"429","author":"Laigre","year":"2016","journal-title":"Carbohydr. Res."},{"key":"10.1194\/jlr.R086629_bib117","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","article-title":"Isofagomine induced stabilization of glucocerebrosidase","volume":"9","author":"Kornhaber","year":"2008","journal-title":"ChemBioChem."},{"key":"10.1194\/jlr.R086629_bib118","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1021\/acs.biochem.6b00363","article-title":"Hydrophobic interactions contribute to conformational stabilization of endoglycoceramidase II by mechanism-based probes","volume":"55","author":"Ben Bdira","year":"2016","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R086629_bib119","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet."},{"key":"10.1194\/jlr.R086629_bib120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1194\/jlr.R086629_bib121","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1194\/jlr.R086629_bib122","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1073\/pnas.93.10.4638","article-title":"Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis","volume":"93","author":"Ichikawa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R086629_bib123","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/mp200313e","article-title":"Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase","volume":"8","author":"Abian","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1194\/jlr.R086629_bib124","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R086629_bib125","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1002\/anie.200902620","article-title":"Glycosphingolipids\u2013nature, function, and pharmacological modulation","volume":"48","author":"Wennekes","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1194\/jlr.R086629_bib126","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"273","author":"Overkleeft","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib127","doi-asserted-by":"crossref","first-page":"e21758","DOI":"10.1371\/journal.pone.0021758","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease","volume":"6","author":"Ashe","year":"2011","journal-title":"PLoS One."},{"key":"10.1194\/jlr.R086629_bib128","doi-asserted-by":"crossref","first-page":"e0135889","DOI":"10.1371\/journal.pone.0135889","article-title":"Reducing GBA2 activity ameliorates neuropathology in Niemann-Pick type C mice","volume":"10","author":"Marques","year":"2015","journal-title":"PLoS One."},{"key":"10.1194\/jlr.R086629_bib129","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R086629_bib130","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/jm901281m","article-title":"Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation","volume":"53","author":"Wennekes","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.R086629_bib131","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1021\/jm501181z","article-title":"Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase\/neutral glucosylceramidase inhibitors","volume":"57","author":"Ghisaidoobe","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.R086629_bib132","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"Aerts","year":"2007","journal-title":"Diabetes."},{"key":"10.1194\/jlr.R086629_bib133","doi-asserted-by":"crossref","first-page":"e38520","DOI":"10.1371\/journal.pone.0038520","article-title":"Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism","volume":"7","author":"Lombardo","year":"2012","journal-title":"PLoS One."},{"key":"10.1194\/jlr.R086629_bib134","doi-asserted-by":"crossref","first-page":"e4723","DOI":"10.1371\/journal.pone.0004723","article-title":"Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation","volume":"4","author":"van Eijk","year":"2009","journal-title":"PLoS One."},{"key":"10.1194\/jlr.R086629_bib135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.plipres.2009.03.002","article-title":"Glycosphingolipids and insulin resistance","volume":"48","author":"Langeveld","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1194\/jlr.R086629_bib136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4614-0650-1_7","article-title":"Glycosphingolipids and insulin resistance","volume":"721","author":"Aerts","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1194\/jlr.R086629_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7164\/antibiotics.43.49","article-title":"Production, isolation and structure determination of a novel beta-glucosidase inhibitor, cyclophellitol, from Phellinus sp","volume":"43","author":"Atsumi","year":"1990","journal-title":"J. Antibiot. (Tokyo)."},{"key":"10.1194\/jlr.R086629_bib138","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0003-9861(92)90685-P","article-title":"Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice","volume":"297","author":"Atsumi","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.R086629_bib139","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/abbi.1993.1353","article-title":"Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol","volume":"304","author":"Atsumi","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.R086629_bib140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0065-2318(08)60034-7","article-title":"Glycoside hydrolases: mechanistic information from studies with reversible and irreversible inhibitors","volume":"48","author":"Legler","year":"1990","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1194\/jlr.R086629_bib141","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pro.5560040302","article-title":"Approaches to labeling and identification of active site residues in glycosidases","volume":"4","author":"Withers","year":"1995","journal-title":"Protein Sci."},{"key":"10.1194\/jlr.R086629_bib142","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1002\/chem.201404014","article-title":"From covalent glycosidase inhibitors to activity-based glycosidase probes","volume":"20","author":"Willems","year":"2014","journal-title":"Chemistry."},{"key":"10.1194\/jlr.R086629_bib143","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1016\/S0021-9258(19)42174-1","article-title":"Affinity labeling of the active sites in the sucrase-isomaltase complex from small intestine","volume":"249","author":"Quaroni","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib144","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/glycob\/cwn041","article-title":"Covalent inhibitors of glycosidases and their applications in biochemistry and biology","volume":"18","author":"Rempel","year":"2008","journal-title":"Glycobiology."},{"key":"10.1194\/jlr.R086629_bib145","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1016\/S0021-9258(18)92727-4","article-title":"Human lysosomal alpha-glucosidase. Characterization of the catalytic site","volume":"266","author":"Hermans","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib146","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1984.tb07947.x","article-title":"Identification of an essential carboxylate group at the active site of lacZ\u03b2-galactosidase from Escherichia coli","volume":"138","author":"Herrchen","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.R086629_bib147","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1016\/S0021-9258(19)49884-0","article-title":"Glu-537, not Glu-461, is the nucleophile in the active site of (lac Z) beta-galactosidase from Escherichia coli","volume":"267","author":"Gebler","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib148","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1016\/S0021-9258(19)78077-6","article-title":"Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry","volume":"269","author":"Miao","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib149","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0006-291X(89)92164-5","article-title":"Conduritol aziridine: a new mechanism-based glucosidase inactivator","volume":"163","author":"Caron","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R086629_bib150","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1021\/bi962963+","article-title":"Structure of the endoglucanase I from Fusarium oxysporum: native, cellobiose, and 3, 4-epoxybutyl \u03b2-D-cellobioside-inhibited forms, at 2.3 \u00c5 resolution","volume":"36","author":"Sulzenbacher","year":"1997","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R086629_bib151","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1021\/bi953052n","article-title":"Covalent binding of three epoxyalkyl xylosides to the active site of endo-1, 4-xylanase II from Trichoderma reesei","volume":"35","author":"Havukainen","year":"1996","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R086629_bib152","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1471-4159.1978.tb12395.x","article-title":"The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects","volume":"30","author":"Stephens","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1194\/jlr.R086629_bib153","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.4751","article-title":"Delineating pathological pathways in a chemically induced mouse model of Gaucher disease","volume":"239","author":"Vardi","year":"2016","journal-title":"J. Pathol."},{"key":"10.1194\/jlr.R086629_bib154","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/hep.510280121","article-title":"Expression of cytosolic \u03b2-glucosidase in guinea pig liver cells","volume":"28","author":"Hays","year":"1998","journal-title":"Hepatology."},{"key":"10.1194\/jlr.R086629_bib155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.1449","article-title":"Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets","volume":"94","author":"Morjani","year":"2001","journal-title":"Int. J. Cancer."},{"key":"10.1194\/jlr.R086629_bib156","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/B616590G","article-title":"Structural basis for cyclophellitol inhibition of a \u03b2-glucosidase","volume":"5","author":"Gloster","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"10.1194\/jlr.R086629_bib157","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nchembio.466","article-title":"Ultrasensitive in situ visualization of active glucocerebrosidase molecules","volume":"6","author":"Witte","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib158","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.1002\/anie.201207771","article-title":"Novel activity-based probes for broad-spectrum profiling of retaining \u03b2-exoglucosidases in situ and in vivo","volume":"51","author":"Kallemeijn","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1194\/jlr.R086629_bib159","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-800128-8.00004-2","article-title":"Mechanism-based inhibitors of glycosidases: design and applications","volume":"71","author":"Kallemeijn","year":"2014","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1194\/jlr.R086629_bib160","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1002\/ejoc.201402589","article-title":"Synthesis of \u03b1-and \u03b2-galactopyranose-configured isomers of cyclophellitol and cyclophellitol aziridine","volume":"2014","author":"Willems","year":"2014","journal-title":"Eur. J. Org. Chem."},{"key":"10.1194\/jlr.R086629_bib161","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acscentsci.6b00057","article-title":"Detection of active mammalian GH31 \u03b1-glucosidases in health and disease using in-class, broad-spectrum activity-based probes","volume":"2","author":"Jiang","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"10.1194\/jlr.R086629_bib162","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/C4SC03739A","article-title":"In vitro and in vivo comparative and competitive activity-based protein profiling of GH29 \u03b1-L-fucosidases","volume":"6","author":"Jiang","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1194\/jlr.R086629_bib163","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cbic.201600561","article-title":"A specific activity-based probe to monitor family GH59 galactosylceramidase, the enzyme deficient in Krabbe disease","volume":"18","author":"Marques","year":"2017","journal-title":"ChemBioChem."},{"key":"10.1194\/jlr.R086629_bib164","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nchembio.2395","article-title":"Activity-based probes for functional interrogation of retaining \u03b2-glucuronidases","volume":"13","author":"Wu","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib165","doi-asserted-by":"crossref","first-page":"e0138107","DOI":"10.1371\/journal.pone.0138107","article-title":"Visualization of active glucocerebrosidase in rodent brain with high spatial resolution following in situ labeling with fluorescent activity based probes","volume":"10","author":"Herrera Moro Chao","year":"2015","journal-title":"PLoS One."},{"key":"10.1194\/jlr.R086629_bib166","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1021\/jacs.7b07352","article-title":"A fluorescence polarization activity-based protein profiling assay in the discovery of potent, selective inhibitors for human non-lysosomal glucosylceramidase","volume":"139","author":"Lahav","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.R086629_bib167","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/acscentsci.7b00214","article-title":"1,6-Cyclophellitol cyclosulfates: a new class of irreversible glycosidase inhibitor","volume":"3","author":"Artola","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1194\/jlr.R086629_bib168","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0076-6879(02)54007-6","article-title":"Trapping covalent intermediates on beta-glycosidases","volume":"354","author":"Wicki","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1194\/jlr.R086629_bib169","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1074-5521(01)00038-2","article-title":"Rapid screening of the aglycone specificity of glycosidases: applications to enzymatic synthesis of oligosaccharides","volume":"8","author":"Blanchard","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1194\/jlr.R086629_bib170","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/35090602","article-title":"Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate","volume":"412","author":"Vocadlo","year":"2001","journal-title":"Nature."},{"key":"10.1194\/jlr.R086629_bib171","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1021\/ja00233a045","article-title":"Identification of a covalent. alpha-D-glucopyranosyl enzyme intermediate formed on a. beta.-glucosidase","volume":"110","author":"Withers","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.R086629_bib172","doi-asserted-by":"crossref","first-page":"32025","DOI":"10.1074\/jbc.272.51.32025","article-title":"Cytosolic pyridoxine-\u03b2-d-glucoside hydrolase from porcine jejunal mucosa. Purification, properties, and comparison with broad specificity \u03b2-glucosidase","volume":"272","author":"McMahon","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R086629_bib173","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1046\/j.1432-1327.2000.01784.x","article-title":"Differential mechanism-based labeling and unequivocal activity assignment of the two active sites of intestinal lactase\/phlorizin hydrolase","volume":"267","author":"Arribas","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.R086629_bib174","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1002\/anie.200454235","article-title":"A strategy for functional proteomic analysis of glycosidase activity from cell lysates","volume":"43","author":"Vocadlo","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1194\/jlr.R086629_bib175","doi-asserted-by":"crossref","first-page":"35126","DOI":"10.1074\/jbc.M508434200","article-title":"Active-site peptide \u201cfingerprinting\u201d of glycosidases in complex mixtures by mass spectrometry discovery of a novel retaining \u03b2-1, 4-glycanase in Cellulomonas fimi","volume":"280","author":"Hekmat","year":"2005","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520341523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520341523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R086629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T13:05:56Z","timestamp":1637413556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520341523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":175,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0022227520341523"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r086629","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}